Cambridge Nutritional Sciences (FRA:RVKA) Cyclically Adjusted Book per Share: €0.11 (As of Sep. 2025)


What is Cambridge Nutritional Sciences Cyclically Adjusted Book per Share?

Cambridge Nutritional Sciences FRA:RVKA Cyclically Adjusted Book per Share is €0.11 as of Sep. 2025. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Cambridge Nutritional Sciences's adjusted book value per share data for the fiscal year that ended in Mar. 2025 was €0.057. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.11 for the trailing ten years ended in Mar. 2025.

During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -6.70% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -4.30% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -6.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Cambridge Nutritional Sciences was -2.00% per year. The lowest was -14.50% per year. And the median was -6.75% per year.

As of today (2026-07-04), Cambridge Nutritional Sciences's current stock price is € 0.014. Cambridge Nutritional Sciences's Cyclically Adjusted Book per Share for the fiscal year that ended in Mar. 2025 was €0.11. Cambridge Nutritional Sciences's Cyclically Adjusted PB Ratio of today is 0.13.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Cambridge Nutritional Sciences was 6.29. The lowest was 0.11. And the median was 0.59.


Cambridge Nutritional Sciences  (FRA:RVKA) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Cambridge Nutritional Sciences's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.014/0.11
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Cambridge Nutritional Sciences was 6.29. The lowest was 0.11. And the median was 0.59.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Cambridge Nutritional Sciences Cyclically Adjusted Book per Share Related Terms


Cambridge Nutritional Sciences Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Cambridge Nutritional Sciences's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cambridge Nutritional Sciences Cyclically Adjusted Book per Share Chart

Cambridge Nutritional Sciences Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.18 0.16 0.18 0.17 0.11

Cambridge Nutritional Sciences Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.17 0.00 0.11 0.00

FRA:RVKA vs ISRG, BDX, MDLN: Cyclically Adjusted Book per Share Comparison

For the Medical Instruments & Supplies subindustry, Cambridge Nutritional Sciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cambridge Nutritional Sciences Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cambridge Nutritional Sciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Cambridge Nutritional Sciences's Cyclically Adjusted PB Ratio falls into.



Cambridge Nutritional Sciences Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cambridge Nutritional Sciences's adjusted Book Value per Share data for the fiscal year that ended in Mar. 2025 was:

Adj_Book=Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.057/136.1000*136.1000
=0.057

Current CPI (Mar. 2025) = 136.1000.

Cambridge Nutritional Sciences Annual Data

Book Value per Share CPI Adj_Book
201603 0.235 100.400 0.319
201703 0.225 102.700 0.298
201803 0.151 105.100 0.196
201903 0.165 107.000 0.210
202003 0.100 108.600 0.125
202103 0.149 109.700 0.185
202203 0.077 116.500 0.090
202303 0.047 126.800 0.050
202403 0.048 131.600 0.050
202503 0.057 136.100 0.057

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €0.11 mean?
Cambridge Nutritional Sciences (FRA:RVKA) has a Cyclically Adjusted Book per Share of €0.11 as of Sep. 2025. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Cambridge Nutritional Sciences and its competitors.
Is Cambridge Nutritional Sciences' Cyclically Adjusted Book per Share too high?
Cambridge Nutritional Sciences' current Cyclically Adjusted Book per Share is €0.11.
How does Cambridge Nutritional Sciences' Cyclically Adjusted Book per Share compare to ISRG and BDX?
Cambridge Nutritional Sciences' Cyclically Adjusted Book per Share of €0.11 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Cambridge Nutritional Sciences and its competitors. Cambridge Nutritional Sciences's current Cyclically Adjusted Book per Share is €0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cambridge Nutritional Sciences stock overvalued right now?
Cambridge Nutritional Sciences (FRA:RVKA) has a current Cyclically Adjusted Book per Share of €0.11. The stock's GF Value™ is €0.02, compared to a current price of €0.01 — trading 30% below its estimated fair value. The current Cyclically Adjusted Book per Share is €0.11. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Cambridge Nutritional Sciences (FRA:RVKA), the current Cyclically Adjusted Book per Share is €0.11 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cambridge Nutritional Sciences Business Description

Other Exchanges CNSL:UK
Address One Fleet Place, London, GBR, EC4M 7WS
Cambridge Nutritional Sciences PLC is a medical diagnostics company specializing in the development, manufacture, and distribution of food sensitivity test kits. Its product portfolio includes tests designed to detect immune reactions to various foods, helping healthcare professionals and patients identify dietary and lifestyle changes to improve long-term health and wellbeing. The company operates in the United Kingdom and serves the customer base across various countries through laboratories and healthcare providers. It generates revenue by selling diagnostic kits and providing clinical analysis services centered on food sensitivity and gut health. The group has two reportable segments: Health and Nutrition; and Corporate. The Health and Nutrition segment generates majority revenue.